JP2012526139A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012526139A5 JP2012526139A5 JP2012509967A JP2012509967A JP2012526139A5 JP 2012526139 A5 JP2012526139 A5 JP 2012526139A5 JP 2012509967 A JP2012509967 A JP 2012509967A JP 2012509967 A JP2012509967 A JP 2012509967A JP 2012526139 A5 JP2012526139 A5 JP 2012526139A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- seq
- inhibitor
- agent
- cdr2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17631709P | 2009-05-07 | 2009-05-07 | |
| US61/176,317 | 2009-05-07 | ||
| PCT/US2010/033845 WO2010129752A1 (en) | 2009-05-07 | 2010-05-06 | Compositions and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or both |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012526139A JP2012526139A (ja) | 2012-10-25 |
| JP2012526139A5 true JP2012526139A5 (https=) | 2013-12-05 |
Family
ID=42272427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012509967A Pending JP2012526139A (ja) | 2009-05-07 | 2010-05-06 | Ｄｉｃｋｋｏｐｆ−１もしくはＤｉｃｋｋｏｐｆ−４または両方に対する結合分子の組成物および使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20120052070A1 (https=) |
| EP (1) | EP2427490A1 (https=) |
| JP (1) | JP2012526139A (https=) |
| KR (1) | KR20120117621A (https=) |
| CN (1) | CN102421798A (https=) |
| AU (1) | AU2010245833B2 (https=) |
| BR (1) | BRPI1014535A2 (https=) |
| CA (1) | CA2759078A1 (https=) |
| MX (1) | MX2011011768A (https=) |
| RU (1) | RU2011149358A (https=) |
| WO (1) | WO2010129752A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR075989A1 (es) * | 2009-04-10 | 2011-05-11 | Lilly Co Eli | Anticuerpo dkk -1 (dickkopf-1) humano disenado por ingenieria |
| CN103608037B (zh) * | 2011-02-01 | 2016-04-13 | 香港大学 | 抗dkk1单克隆抗体用于治疗肝癌的用途 |
| CN103487581A (zh) * | 2012-06-08 | 2014-01-01 | 上海市肿瘤研究所 | 血清dkk1在制备甲胎蛋白阴性肝细胞癌的诊断试剂中的用途 |
| CN103472226A (zh) * | 2012-06-08 | 2013-12-25 | 上海市肿瘤研究所 | 血清dkk1在制备早期肝细胞癌或小肝细胞癌的诊断试剂中的用途 |
| CN104837502B (zh) | 2012-10-12 | 2018-08-10 | 麦迪穆有限责任公司 | 吡咯并苯并二氮杂卓及其结合物 |
| CN103083686B (zh) * | 2013-02-18 | 2014-09-10 | 上海交通大学医学院附属仁济医院 | Dkk4基因及其编码蛋白在制备药物中的应用 |
| CA2905181C (en) | 2013-03-13 | 2020-06-02 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof for providing targeted therapy |
| JP6531166B2 (ja) | 2014-09-10 | 2019-06-12 | メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ | ピロロベンゾジアゼピン及びそのコンジュゲート |
| CN104258397A (zh) * | 2014-09-29 | 2015-01-07 | 武汉大学 | Dickkopf-3在治疗动脉粥样硬化中的功能和应用 |
| CN105145470A (zh) * | 2015-07-08 | 2015-12-16 | 上海交通大学医学院附属瑞金医院 | 成熟脂肪组织β-catenin敲除的小鼠模型的构建方法 |
| CN109862919A (zh) | 2016-10-11 | 2019-06-07 | 免疫医疗有限公司 | 抗体-药物缀合物联合免疫介导的治疗剂 |
| KR102701695B1 (ko) | 2016-10-26 | 2024-08-30 | 리프 테라퓨틱스 인코포레이티드 | 항-dkk-1 항체를 사용하여 암을 치료하기 위한 바이오마커로서의 베타-카테닌의 용도 |
| CN106811545B (zh) * | 2017-04-10 | 2020-04-03 | 北京医院 | 一种预测高甘油三酯血症的易感性的方法与试剂 |
| CA3098103A1 (en) | 2018-05-23 | 2019-11-28 | Adc Therapeutics Sa | Molecular adjuvant |
| KR20210038893A (ko) * | 2018-07-31 | 2021-04-08 | 에프. 호프만-라 로슈 아게 | 심방 세동의 평가에서 순환하는 dkk3(딕오프 관련 단백질 3) |
| CN112121147B (zh) * | 2019-06-24 | 2023-07-04 | 中国人民解放军海军特色医学中心 | 多肽在治疗或预防骨髓瘤药物中的应用、多肽、核酸、药物及重组表达载体 |
| CN112180094A (zh) * | 2019-07-04 | 2021-01-05 | 上海东慈生物科技有限公司 | Dkk1抑制剂在预防和/或治疗肿瘤恶病质与糖尿病伴随疾病中的应用 |
| US20230372528A1 (en) | 2020-10-16 | 2023-11-23 | University Of Georgia Research Foundation, Inc. | Glycoconjugates |
| GB202102396D0 (en) | 2021-02-19 | 2021-04-07 | Adc Therapeutics Sa | Molecular adjuvant |
| CN117980327A (zh) | 2021-11-03 | 2024-05-03 | 杭州多禧生物科技有限公司 | 抗体的特异性偶联 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL157328A0 (en) * | 2001-02-16 | 2004-02-19 | Genentech Inc | Treatment involving dkk-1 or antagonists thereof |
| IL158750A0 (en) * | 2001-05-17 | 2004-05-12 | Genome Therapeutics Corp | Reagents and methods for modulating dkk-mediated interactions |
| MX2007001221A (es) * | 2004-08-04 | 2007-03-23 | Amgen Inc | Anticuerpos para proteina dickkopf-1 (dkk-1). |
| AR060017A1 (es) * | 2006-01-13 | 2008-05-21 | Novartis Ag | Composiciones y metodos de uso para anticuerpos de dickkopf -1 |
| CA2685737A1 (en) * | 2007-04-30 | 2008-11-06 | Washington University | Methods and compositions for the treatment of cancer |
| CA2705923A1 (en) * | 2007-11-16 | 2009-05-22 | Nuvelo, Inc. | Antibodies to lrp6 |
-
2010
- 2010-05-06 CN CN201080019959XA patent/CN102421798A/zh active Pending
- 2010-05-06 WO PCT/US2010/033845 patent/WO2010129752A1/en not_active Ceased
- 2010-05-06 JP JP2012509967A patent/JP2012526139A/ja active Pending
- 2010-05-06 MX MX2011011768A patent/MX2011011768A/es unknown
- 2010-05-06 AU AU2010245833A patent/AU2010245833B2/en not_active Ceased
- 2010-05-06 US US13/265,900 patent/US20120052070A1/en not_active Abandoned
- 2010-05-06 KR KR1020117029170A patent/KR20120117621A/ko not_active Withdrawn
- 2010-05-06 BR BRPI1014535A patent/BRPI1014535A2/pt not_active IP Right Cessation
- 2010-05-06 RU RU2011149358/02A patent/RU2011149358A/ru unknown
- 2010-05-06 CA CA2759078A patent/CA2759078A1/en not_active Abandoned
- 2010-05-06 EP EP10719858A patent/EP2427490A1/en not_active Withdrawn
-
2013
- 2013-06-12 US US13/915,723 patent/US20140134173A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012526139A5 (https=) | ||
| RU2011149358A (ru) | Композиции и способы применения молекул, связывающихся с белком dickkopf-1 или с белком dickkopf-4, или с обоими указанными белками | |
| JP6505153B2 (ja) | がん細胞の転移を予防するための化合物、組成物および方法 | |
| DK2799427T3 (en) | Therapeutic compounds | |
| US11034666B2 (en) | Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds | |
| RU2005119646A (ru) | Конденсированные бициклические азотсодержащие гетероциклы | |
| NZ601794A (en) | Di - substituted pyridine derivatives as anticancers | |
| JP2019504898A5 (https=) | ||
| AU2012224499B2 (en) | New pyridazinone and pyridone compounds | |
| Tilekar et al. | Thiazolidinedione “magic bullets” simultaneously targeting PPARγ and HDACs: Design, synthesis, and investigations of their in vitro and in vivo antitumor effects | |
| US20220160672A1 (en) | Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof | |
| RU2020136310A (ru) | Ингибиторы atf6 и их применение | |
| JP2006500384A5 (https=) | ||
| JP2013518909A (ja) | アロステリックキナーゼ阻害が関係する治療方法および組成物 | |
| JP2007536224A5 (https=) | ||
| JP2014526492A5 (https=) | ||
| CN105008323A (zh) | 纤溶酶原激活物抑制因子-1抑制剂和其使用方法 | |
| EP4527464A2 (en) | Novel 3, 5-disubstituted pyridine and 3, 5-disubstituted pyridazine derivatives and pharmaceutical use of same | |
| JP2007504160A5 (https=) | ||
| WO2010059239A3 (en) | Lactate salt of 4-(6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disorders | |
| JP2010516699A (ja) | Ｐｐａｒモジュレータとして有用な置換１，３−ジオキサン | |
| CN102976928A (zh) | 用于降低尿酸的化合物 | |
| EA025199B1 (ru) | Гетероциклические соединения, подходящие для лечения дислипидемии | |
| KR101446301B1 (ko) | Cxcr3/cxcl10 길항제 화합물, 이의 제조방법 및 이를 포함하는 골 전이의 예방 및 치료용 약학 조성물 | |
| JP2016522196A5 (https=) |